Cerebrospinal Fluid Management Market
Cerebrospinal Fluid (CSF) Management Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Product (CSF Shunts, External Drainage Systems); By End User (Pediatric, Adult, Geriatric); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
- Published Date: April 2024
- Report ID: BWC24279
- Available Format: PDF
- Page: 400
Report Overview
The increasing burden of hydrocephalus and other neurological disorders and growing geriatric population are expected to boost the growth of Global Cerebrospinal Fluid (CSF) Management Market during the forecast period between 2024 and 2030.Global Cerebrospinal Fluid (CSF) Management Market - Industry Trends & Forecast Report, 2030
The Global Cerebrospinal Fluid (CSF) Management Market size was estimated to be worth USD 1.37 billion in 2023. During the forecast period between 2024 and 2030, the Global Cerebrospinal Fluid (CSF) Management Market size is projected to grow at a CAGR of 5.12%, reaching a value of USD 2.98 billion by 2030. Major growth factors for the Global Cerebrospinal Fluid (CSF) Management Market include the increasing prevalence of medical conditions associated with CSF, such as hydrocephalus, meningitis, and subarachnoid hemorrhage. Additionally, the growing geriatric population and rising prevalence of diseases such as Alzheimer's and Parkinson’s disease are anticipated to drive the Global Cerebrospinal Fluid (CSF) Management Market during the period in analysis.
Cerebrospinal Fluid (CSF) Management – Overview
Cerebrospinal fluid, or CSF, is essentially a colorless fluid composed of many cells that are present in the brain and spinal cord. It helps the body's central nervous system get nutrients by eliminating waste products and also gives the brain mechanical and immunological protection. A condition known as CSF leak occurs when there is a breach in the surrounding dura that allows CSF to escape from the subarachnoid area. The quantity of CSF leaked in a leak can vary greatly, going from negligible to enormous volumes.
Global Cerebrospinal Fluid (CSF) Management Market
Growth Drivers
Increasing Burden of Hydrocephalus and other Neurological Disorders
The increasing prevalence of hydrocephalus and other neurological disorders is emerging as a major growth factor for the Global Cerebrospinal Fluid (CSF) Management Market. The National Institutes of Health published a paper estimating the prevalence of hydrocephalus to be 85 per 100,000 people worldwide, with significant age-group differences of 11 per 100,000 for adults and 88 per 100,000 for children. About one or two newborns born in the United States have congenital (inborn) hydrocephalus, as reported by John Hopkins Medicine.
Challenges
Complications associated with CSF Shunt Procedure
The complications arising from the CSF shunt procedure for the treatment of hydrocephalus may result in its limited demand among patients. According to the Food and Drug Administration (FDA), the CSF shunt procedure may lead to infection and lead to symptoms such as low-grade fever and soreness of the neck. The procedure may also cause shunt malfunction, over drainage, and under drainage, which may result in fluid drain or buildup and increase the chances of recurrence of hydrocephalus symptoms. This acts as a major limiting factor for the global cerebrospinal fluid (CSF) management market.
Impact of Escalating Geopolitical Tensions on Global Cerebrospinal Fluid (CSF) Management Market
The escalating geopolitical tensions negatively impact the growth of the Global Cerebrospinal Fluid (CSF) Management Market. Situations like war, conflicts, and genocide impact the patient’s accessibility to proper healthcare services and result in a shortage of medical supplies. Russia and Israel, for instance, destroyed several hospitals in Ukraine and Palestine, respectively, which resulted in the breakdown of the entire healthcare system and the displacement of many healthcare workers. Many other countries that are facing geopolitical tensions have limited resources to acquire medical supplies for performing cerebrospinal fluid (CSF) management, which limits its global market growth.
Global Cerebrospinal Fluid (CSF) Management Market
Segmental Coverage
Global Cerebrospinal Fluid (CSF) Management Market – By Product
Based on product, the Global Cerebrospinal Fluid (CSF) Management Market is split into CSF shunts and external drainage systems segments. The CSF shunts segment holds a larger share in the Global Cerebrospinal Fluid (CSF) Management Market. The increasing prevalence of hydrocephalus is directly influencing the growth of shunt procedures worldwide. According to a paper published on NCBI, the global incidence of hydrocephalus is around 88 cases per 100,000 children and 11 cases per 100,000 adults, which is boosting the demand for CSF shunt procedures.
Global Cerebrospinal Fluid (CSF) Management Market – By End User
Based on the end user, the Global Cerebrospinal Fluid (CSF) Management Market is segmented into pediatric, adult, and geriatric. The pediatric segment accounts for the highest market share owing to the increasing prevalence of congenital hydrocephalus among children. Overabundance of cerebrospinal fluid (CSF) in the brain from birth results in congenital hydrocephalus. As a result, the number of shunt procedures performed on children is also rising at a high rate, driving the Global Cerebrospinal Fluid (CSF) Management Market.
Global Cerebrospinal Fluid (CSF) Management Market – By Region
The in-depth research report on the Global Cerebrospinal Fluid (CSF) Management Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Cerebrospinal Fluid (CSF) Management Market. The growth of the market is mainly attributed to the increasing geriatric population and the prevalence of nervous disorders. Furthermore, extensive research and development activities in this field and approvals of new products by the US FDA are anticipated to present lucrative growth opportunities to the cerebrospinal fluid (CSF) management market during the forecast period.
Competitive Landscape
Major players operating in the Global Cerebrospinal Fluid (CSF) Management Market include Medtronic Plc, B. Braun Melsungen AG, Integra Lifesciences, Natus Medical Incorporated, Sophysa, Aesculap AG, Spiegelberg GmbH & Co. KG, Moeller Medica, IRRAS AB, Argi Group, and Sophysa.
These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
Recent Developments
-
In June 2023 – Roche, a global biopharmaceutical company based in Switzerland, announced that it had received FDA 510(k) clearance for its Elecsys beta-amyloid (1-42) CSF II and Elecsys Total-Tau CSF assays (tTau).
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2023 |
Base Year – 2023 |
|
Estimated Year – 2024 |
|
Forecast Period – 2024–2030 |
|
Facts Covered |
Revenue in USD Billion |
Market Coverage |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Product/ Service Segmentation |
Product, End User, Region |
Key Players |
Medtronic Plc, B. Braun Melsungen AG, Integra Lifesciences, Natus Medical Incorporated, Sophysa, Aesculap AG, Spiegelberg GmbH & Co. KG, Moeller Medica, IRRAS AB, Argi Grup, Sophysa |
By Product
-
CSF Shunts
-
External Drainage Systems
By End User
-
Pediatric
-
Adult
-
Geriatric
By Region
-
North America
-
Europe
-
Asia Pacific (APAC)
-
Latin America (LATAM)
-
Middle East and Africa (MEA)
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Executive Summary
- Global Cerebrospinal Fluid (CSF) Management Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- Increasing Burden of Hydrocephalus and Other Neurological Disorders
- Growing Geriatric Population
- Increasing Healthcare Awareness
- Growing Adoption of Minimally Invasive Solutions
- Restraints
- High Cost of Procedures and Devices
- Lack of Awareness of Treatment Options
- Dearth of Skilled Professionals
- Opportunities
- Advancements in Minimally Invasive Surgical Techniques and Development of New CSF Drainage Devices
- Focus on Minimally Invasive Procedures
- Integration of Telemedicine and Remote Monitoring with CSF Management Devices
- Challenges
- Reimbursement Challenges
- Cybersecurity Threats
- Growth Drivers
- Technological Advancements/Recent Developments
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Global Cerebrospinal Fluid (CSF) Management Market: Marketing Strategies
- Global Cerebrospinal Fluid (CSF) Management Market, Geographical Analysis, 2023
- Global Cerebrospinal Fluid (CSF) Management Market, Geographical Analysis, 2023
- Global Cerebrospinal Fluid (CSF) Management Market, Market Attractiveness Analysis, 2024-2030
- Global Cerebrospinal Fluid (CSF) Management Market Overview
- Market Size & Forecast, 2019–2030
- By Value (USD Billion)
- Market Share and Forecast
- By Product
- CSF Shunts
- External Drainage Systems
- By End User
- Pediatric
- Adult
- Geriatric
- By Region
- North America
- Europe
- Asia Pacific (APAC)
- Latin America (LATAM)
- Middle East and Africa (MEA)
- By Product
- Market Size & Forecast, 2019–2030
- North America Cerebrospinal Fluid (CSF) Management Market
- Market Size & Forecast, 2019–2030
- Market Share & Forecast
- By Product
- By End User
- By Country
- United States
- By Product
- By End User
- Canada
- By Product
- By End User
- United States
- Europe Cerebrospinal Fluid (CSF) Management Market
- Market Size & Forecast, 2019–2030
- By Value (USD Billion)
- Market Share & Forecast
- By Product
- By End User
- By Country
- Germany
- By Product
- By End User
- United Kingdom
- By Product
- By End User
- Italy
- By Product
- By End User
- France
- By Product
- By End User
- Spain
- By Product
- By End User
- Belgium
- By Product
- By End User
- Russia
- By Product
- By End User
- Rest of Europe
- By Product
- By End User
- Germany
- Market Size & Forecast, 2019–2030
- Asia Pacific Cerebrospinal Fluid (CSF) Management Market
- Market Size & Forecast, 2019–2030
- By Value (USD Billion)
- Market Share & Forecast
- By Product
- By End User
- By Country
- China
- By Product
- By End User
- India
- By Product
- By End User
- Japan
- By Product
- By End User
- South Korea
- By Product
- By End User
- Australia & New Zealand
- By Product
- By End User
- Indonesia
- By Product
- By End User
- Malaysia
- By Product
- By End User
- Singapore
- By Product
- By End User
- Vietnam
- By Product
- By End User
- Rest of APAC
- By Product
- By End User
- China
- Market Size & Forecast, 2019–2030
- Latin America Cerebrospinal Fluid (CSF) Management Market
- Market Size & Forecast, 2019–2030
- By Value (USD Billion)
- Market Share & Forecast
- By Product
- By End User
- By Country
- Brazil
- By Product
- By End User
- Mexico
- By Product
- By End User
- Argentina
- By Product
- By End User
- Peru
- By Product
- By End User
- Rest of LATAM
- By Product
- By End User
- Brazil
- Market Size & Forecast, 2019–2030
- Middle East & Africa Cerebrospinal Fluid (CSF) Management Market
- Market Size & Forecast, 2019–2030
- By Value (USD Billion)
- Market Share & Forecast
- By Product
- By End User
- By Country
- Saudi Arabia
- By Product
- By End User
- UAE
- By Product
- By End User
- Qatar
- By Product
- By End User
- Kuwait
- By Product
- By End User
- South Africa
- By Product
- By End User
- Nigeria
- By Product
- By End User
- Algeria
- By Product
- By End User
- Rest of MEA
- By Product
- By End User
- Saudi Arabia
- Market Size & Forecast, 2019–2030
- Competitive Landscape
- List of Key Players and Their Offerings
- Global Cerebrospinal Fluid (CSF) Management Market Share Analysis, 2023
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
- Impact of Escalating Geopolitical Tensions on Global Cerebrospinal Fluid (CSF) Management Market
- Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- Medtronic Plc
- B. Braun Melsungen AG
- Integra Lifesciences
- Natus Medical Incorporated
- Sophysa
- Aesculap AG
- Spiegelberg GmbH & Co. KG
- Moeller Medica
- IRRAS AB
- Argi Grup
- Sophysa
- Other Prominent Players
- Key Strategic Recommendations
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Region
- Assumptions & Limitations
- Qualitative Research
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
Figure 1 Global Cerebrospinal Fluid (CSF) Management Market Segmentation
Figure 2 Global Cerebrospinal Fluid (CSF) Management Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 Global Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 5 Global Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 6 Global Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 7 Global Cerebrospinal Fluid (CSF) Management Market Share, By Region, By Value, 2019−2030
Figure 8 North America Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 9 North America Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 10 North America Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 11 North America Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019−2030
Figure 12 United States Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 13 United States Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 14 United States Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 15 Canada Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 16 Canada Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 17 Canada Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 18 Europe Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 19 Europe Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 20 Europe Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 21 Europe Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019−2030
Figure 22 Germany Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 23 Germany Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 24 Germany Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 25 United Kingdom Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 26 United Kingdom Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 27 United Kingdom Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 28 Italy Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 29 Italy Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 30 Italy Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 31 France Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 32 France Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 33 France Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 34 Spain Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 35 Spain Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 36 Spain Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 37 Belgium Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 38 Belgium Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 39 Belgium Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 40 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 41 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Share, By Technology, By Value, 2019−2030
Figure 42 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 43 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 44 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 45 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Share, By Deployment, By Value, 2019−2030
Figure 46 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019−2030
Figure 47 China Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 48 China Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 49 China Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 50 India Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 51 India Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 52 India Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 53 Japan Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 54 Japan Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 55 Japan Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 56 South Korea Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 57 South Korea Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 58 South Korea Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 59 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 60 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 61 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 62 Indonesia Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 63 Indonesia Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 64 Indonesia Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 65 Malaysia Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 66 Malaysia Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 67 Malaysia Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 68 Singapore Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 69 Singapore Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 70 Singapore Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 71 Vietnam Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 72 Vietnam Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 73 Vietnam Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 74 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 75 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 76 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 77 Latin America Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 78 Latin America Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 79 Latin America Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 80 Latin America Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019−2030
Figure 81 Brazil Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 82 Brazil Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 83 Brazil Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 84 Mexico Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 85 Mexico Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 86 Mexico Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 87 Argentina Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 88 Argentina Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 89 Argentina Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 90 Peru Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 91 Peru Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 92 Peru Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 93 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 94 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Share, By Product By Value, 2019−2030
Figure 95 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 96 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 97 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 98 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 99 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Share, By Country, By Value, 2019−2030
Figure 100 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 101 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 102 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 103 UAE Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 104 UAE Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 105 UAE Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 106 Qatar Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 107 Qatar Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 108 Qatar Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 109 Kuwait Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 110 Kuwait Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 111 Kuwait Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 112 Iran Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 113 Iran Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 114 Iran Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 115 South Africa Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 116 South Africa Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 117 South Africa Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 118 Nigeria Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 119 Nigeria Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 120 Nigeria Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 121 Kenya Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 122 Kenya Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 123 Kenya Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 124 Egypt Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 125 Egypt Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 126 Egypt Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 127 Morocco Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 128 Morocco Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 129 Morocco Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 130 Algeria Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 131 Algeria Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 132 Algeria Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
Figure 133 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Size, By Value (USD Billion), 2019−2030
Figure 134 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Share, By Product, By Value, 2019−2030
Figure 135 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Share, By End User, By Value, 2019−2030
List of Tables
Table 1 Global Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 2 Global Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 3 Global Cerebrospinal Fluid (CSF) Management Market Size, By Region, By Value, 2019−2030
Table 4 North America Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 5 North America Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 6 North America Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019−2030
Table 7 United States Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 8 United States Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 9 Canada Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 10 Canada Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 11 Europe Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 12 Europe Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 13 Europe Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019−2030
Table 14 Germany Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 15 Germany Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 16 United Kingdom Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 17 United Kingdom Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 18 Italy Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 19 Italy Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 20 France Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 21 France Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 22 Spain Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 23 Spain Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 24 Belgium Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 25 Belgium Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 26 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 27 Rest of Europe Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 28 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 29 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 30 Asia Pacific Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019−2030
Table 31 China Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 32 China Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 33 India Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 34 India Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 35 Japan Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 36 Japan Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 37 South Korea Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 38 South Korea Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 39 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 40 Australia & New Zealand Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 41 Indonesia Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 42 Indonesia Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 43 Malaysia Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 44 Malaysia Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 45 Singapore Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 46 Singapore Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 47 Philippines Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 48 Philippines Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 49 Vietnam Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 50 Vietnam Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 51 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 52 Rest of APAC Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 53 Latin America Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 54 Latin America Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 55 Latin America Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019−2030
Table 56 Brazil Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 57 Brazil Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 58 Mexico Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 59 Mexico Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 60 Argentina Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 61 Argentina Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 62 Peru Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 63 Peru Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 64 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 65 Rest of LATAM Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 66 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 67 Middle East & Africa Cerebrospinal Fluid (CSF) Management Market Size, By Country, By Value, 2019−2030
Table 68 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 69 Saudi Arabia Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 70 UAE Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 71 UAE Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 72 Qatar Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 73 Qatar Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 74 Kuwait Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 75 Kuwait Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 76 Iran Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 77 Iran Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 78 South Africa Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 79 South Africa Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 80 Nigeria Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 81 Nigeria Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 82 Kenya Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 83 Kenya Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 84 Egypt Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 85 Egypt Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 86 Morocco Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 87 Morocco Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 88 Algeria Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 89 Algeria Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 90 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Size, By Product, By Value, 2019−2030
Table 91 Rest of MEA Cerebrospinal Fluid (CSF) Management Market Size, By End User, By Value, 2019−2030
Table 92 Medtronic Plc Company Overview
Table 93 Medtronic Plc Company Overview
Table 94 B. Braun Melsungen AG Company Overview
Table 95 B. Braun Melsungen AG Company Overview
Table 96 Integra Lifesciences Company Overview
Table 97 Integra Lifesciences Company Overview
Table 98 Natus Medical Incorporated Company Overview
Table 99 Natus Medical Incorporated Company Overview
Table 100 Sophysa Company Overview
Table 101 Sophysa Company Overview
Table 102 Aesculap AG Company Overview
Table 103 Aesculap AG Company Overview
Table 104 Spiegelberg GmbH & Co. KG Company Overview
Table 105 Spiegelberg GmbH & Co. KG Company Overview
Table 106 Moeller Medica Company Overview
Table 107 Moeller Medica Company Overview
Table 108 IRRAS AB Company Overview
Table 109 IRRAS AB Company Overview
Table 110 Argi Grup Company Overview
Table 111 Argi Grup Company Overview
Table 112 Sophysa Company Overview
Table 113 Sophysa Company Overview
Market Segmentation
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.